Stock Market Today, Jan. 23: ImmunityBio Falls After Gaining Over 200% in a Month

Today, Jan. 23, 2026, profit taking and fresh glioblastoma survival data weighed on a soaring biotech stock.

ImmunityBio Stock Quote

Today’s Change

(-12.13%) $-0.89

Current Price

$6.45

ImmunityBio (IBRX 12.13%), an immunity-focused biotech, closed Friday’s session at $6.45, down 12.13%. The stock is still up 63.29% in the past five days and 207.14% in the past month.

Trading volume reached 74.6 million shares, coming in about 238% above its three-month average of 22.1 million shares. ImmunityBio IPO’d in 2015 and has fallen 83% since going public.

How the markets moved today

The broader markets were relatively steady Friday, with the S&P 500 (^GSPC +0.03%) edging up 0.03% to 6,915 and the Nasdaq Composite (^IXIC +0.28%) rising 0.28% to finish at 23,501. Among biotechnology & pharmaceuticals peers, Merck (MRK 0.98%) and BioNTech (BNTX 2.10%) posted slight losses, underscoring ongoing volatility around oncology and vaccine pipelines.

What this means for investors

ImmunityBio has skyrocketed in recent weeks, and today’s losses could be down to profit taking. In January alone, the company agreed on a pathway with the FDA to resubmit its Anktiva bladder cancer therapy application. And the Saudi FDA granted approval for Anktiva.

Last week, the firm’s full-year results beat analyst expectations. Its net profit of $113 million, was about 700% up year-on-year. Today, it announced that 19 out of 23 patients with progressive glioblastoma receiving Anktiva are still alive, but that median overall survival has not yet been reached.

Several analysts including H.C. Wainwright have raised their price targets for the stock. Finally, exits from short sellers have boosted the cancer drugmaker. with Bloomberg reporting paper losses of around $492 million for short sellers.

Emma Newbery has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Merck. The Motley Fool recommends BioNTech Se. The Motley Fool has a disclosure policy.

Source link

Visited 1 times, 1 visit(s) today

Related Article

SHOP Stock Sell-Off Looks Overdone as Margins and Guidance Shine

Shopify’s NASDAQ: SHOP stock sold off following its Q3 earnings release on fears that may be overblown given the company’s fundamental strength. Ultimately, it comes down to valuation: the approximately 80x current-year consensus earnings multiple it traded at before the release was high, pricing in perfection and leaving little room for weakness. The roughly 1%

If a Stock Market Crash Is Coming, History Says SCHD’s Dividend Grew Through the Last Two Bear Markets. But Here’s the Catch I’m Watching.

With the market on edge these days, especially heading into Friday’s jobs report, a question keeps nagging income investors: What will happen to my dividends if stocks crash? The Schwab U.S. Dividend Equity ETF (SCHD -0.97%) has already endured two bear markets since its inception in 2011. The S&P 500 fell about 34% in early

The Smartest Dividend Stock to Buy With $1,000 Right Now

The market has been down over the past month as investors consider higher interest rates, inflation, and artificial intelligence (AI) spending, and now is a good time to think about defensive plays like dividend stocks. Also, $1,000 is enough to start a position in an excellent dividend stock that should pay you well forever. You

US stock futures fall amid key Democratic midterm election wins

Robert Wolf, a former economic advisor to Obama, and Steve Cortes, a former Trump campaign advisor, discuss the midterm election’s impact on Wall Street. U.S. stock futures fell sharply as Democrats scored key victories in the midterm elections and the Fox News Decision Desk projected the party will take control of both chambers of Congress.

Why Capri Holdings Stock Popped 32% in October

Shares of Capri Holdings (NYSE:CPRI) were on the move last month, jumping at the end of the month on a strong earnings report after earlier gains on speculation of a buyout. Capri also seemed to benefit from a rotation in consumer discretionary stocks as investors sold AI stocks last month. Missed Nvidia in 2009? This

Indonesia regulator announces sanctions for alleged stock market violations

End-of-day quote 2026-11-03 5-day change 1st Jan Change 324.00 IDR -2.41% -3.57% -51.28% Published on 11/03/2026 at 11:16 pm EST Reuters This article is reserved for our members. Log in to continue Log inCreate an account 11:16pm Indonesia regulator announces sanctions for alleged stock market violations RE Oct. 29 PT Panorama Sentrawisata Tbk Reports Earnings

Why Shake Shack Stock Jumped 20% in October

Shake Shack (NYSE:SHAK) stock was moving higher last month in a broader rotation into restaurant stocks as investors sold AI stocks and rotated into undervalued sectors like restaurants. There was no major news item that drove the stock up last month, but Shake Shack did benefit from its announcement that it would expand into Brazil,

Jim Cramer sees signs of life in tech stocks — but not from the usual winners

CNBC’s Jim Cramer said Tuesday that a new group of technology stocks may be emerging as market leaders. While heavyweights such as Nvidia, Microsoft, Alphabet and Meta have struggled to sustain rallies in recent weeks, other companies are showing signs of strength. That was evident during Tuesday’s session as gains from Broadcom and Micron supported

Syndax Pharmaceuticals Stock Gains Focus After Revenue Growth And Pipeline Progress

Syndax Pharmaceuticals reported Q3 2026 revenue of US$83.3 million versus US$45.87 million a year earlier, with the quarterly net loss at US$49.43 million and basic loss per share at US$0.55. The company also announced a CFO transition effective November 9, 2026. Growing contributions from Revuforj and Niktimvo, alongside pipeline spending that kept the business in

Ball (BALL) Stock Looks Reasonable On Its Earnings Support

Ball has logged a strong share price run in the past year, which puts a sharper spotlight on whether the current tag is justified by what the business actually earns. With that kind of move already on the board, the question now is how comfortably Ball’s earnings can carry the valuation. The stock is up

Should You Buy Qualcomm Stock Before Its Nov. 4 Report?

Qualcomm (NASDAQ:QCOM) shares slid 11% on Oct. 30 to close at $164.79. The company didn’t release any news of its own that day. Instead, it was caught in a broad chip sell-off after Intel forecast less revenue in the fourth quarter than in the third and warned the PC slowdown might last until at least

Pinnacle West Capital Corporation Q3 2026 Earnings Call Summary

Pinnacle West Capital Corporation Q3 2026 Earnings Call Summary – Moby Strategic Drivers of Record Growth and Operational Performance Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we’ll show you why it’s our #1 pick. Tap here. Record-breaking summer demand was met through

3 Stocks That Did Well the Last Time the Fed Raised Rates Aggressively

The Federal Reserve recently raised interest rates for the first time in years, and more rate hikes are expected. Another hike may even happen before the end of the year. How much higher rates end up going is anyone’s guess at this point, as inflation remains elevated and the war in Iran doesn’t appear to

November Stock Market Outlook: How to Position Your Portfolio for the Remainder of 2026

Stock Market Outlook Key Takeaways The US stock market is trading at a 10% discount to a composite of our valuations AI enthusiasm is evolving into AI accountability Maintain a barbell-shaped portfolio: Overweight value and growth, underweight core Based on a composite of our intrinsic valuations of the stocks we cover included in the Morningstar

Is Brighthouse Financial, Inc. (BHF) Stock Facing a Major Regulatory Hurdle?

Greenlight Capital, an investment management firm, recently released its Q3 2026 investor letter. A copy of the letter can be downloaded here. The funds returned -3.3% in the third quarter of 2026, compared with a 2.3% gain for the S&P 500, bringing their year-to-date return to -1.5% against the index’s 12.7% advance. The disappointing performance

0
Would love your thoughts, please comment.x
()
x